Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by TheTruth1234on Aug 19, 2023 11:21pm
80 Views
Post# 35596736

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:so is that the end of JD? Prophet?

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:so is that the end of JD? Prophet?
Boomskid wrote: You're wrong, TT. Prophylaxis was discussed by Mark Day, DrDR and RH. The idea was that xB3-001 could kill diffuse tumours before they were detectable. 

As a standard of care, xB3-001 was also discussed in the corporate presentation.

But you never bothered to read anything, TT, you and beenthere.

Maybe you should stick with attacking me. Repetition better suits your natural strengths. 

jd


Nope!  You're wrong Johnny boy. 


That is why YOU ARE BANKRUPT!

<< Previous
Bullboard Posts
Next >>